U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06941584) titled 'Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies' on April 16.
Brief Summary: Studying genetic predisposition in autoimmune neurological diseases could help improve diagnostic accuracy and offer new treatment possibilities
Study Start Date: Nov. 06, 2024
Study Type: OBSERVATIONAL
Condition:
AIRE Deficiency
Intervention:
DIAGNOSTIC_TEST: Test for AQP4, AChR, LGI1, and CASPR2 autoantibodies using cell-based assay
To evaluate the prevalence of specific autoantibodies (AQP4, AChR, LGI1, and CASPR2) in the population of patients carrying AIRE mutations (second cohort)
GENETIC: AIRE ...